SEC Form 4 · accession 0001209191-18-053538

Entasis Therapeutics Holdings Inc. · ETTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Sep 28, 2018

Accepted (ET)

Oct 2, 2018 · 9:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001724344

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Sep 28, 2018	C	359,267	—	A	359,267	I	See Footnote
Common Stock^F1,F3,F2	Sep 28, 2018	C	458,425	—	A	842,454	I	See Footnote
Common Stock^F2	Sep 28, 2018	P	337,724	$15.00	A	1,180,178	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series B-1 Tranche A Convertible Preferred Stock^F2,F1	—	Sep 28, 2018	C	7,446,904	D	—	—	Common Stock	359,267	0	I
Series B-1 Tranche B Convertible Preferred Stock^F2,F1	—	Sep 28, 2018	C	9,502,249	D	—	—	Common Stock	458,425	0	I

F1Each share of Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
F2The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The Reporting Person is a managing partner of Pivotal bioVenture Partners Management Ltd. ("Investment Advisor"), which is the investment advisor to Pivotal, and is managing partner of Pivotal bioVenture Partners Investment Advisor, LLC, which is the U.S. sub-advisor to the Investment Advisor. Therefore, the Reporting Person may be deemed to beneficially own the shares held by Pivotal. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein, if any.
F3This number includes an aggregate of 24,762 shares of Common Stock received by Pivotal upon the conversion of the Issuer's Preferred Stock as payment of the accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018.